Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Info
titlePlease note!

Commonly used concepts and their categories are being added regularly to tables in this guidance document

Table of Contents



General information

Tools for COVID-19 annotation

Annotation widget

  • We have imported the annotation widget, that we use for systematic review annotation, in to the CRS Web
  • If you cannot access the CRS Web please contact Deirdre Beecher

COVID-19Register in CRS Web

  • The register will be listed with any other registers that you access via the CRS Web
  • Search and layout is identical to that in other CRS registers

Annotation status & fields

  • Additional fields have been added to the CRS records to assist us in our workflow
Expand
titleClick here to view additional fields


FieldDescription
Annotated by

 when an annotation is completed this field will be autofilled with the users name

Annotator action

there are two options here, In Progress or Vocabulary Request. 

Annotator notesthis is a free text field


  • Three annotation status are available 
Expand
titleClick here for list ot status


Status

Description

Available for annotation

record is available for anyone to annotate

Annotating 

the record is open and being annotated by another person

Annotated 

annotation has been completed


Basic steps

  1. Search the COVID-19 Register for studies
  2. Login to CRS Web
  3. Select COVID-19 Register (only applies to those who use multiple registers)
  4. Make sure you have ticked IN REGISTER (you do not want to search beyond this)
  5. Search for study using the title or study ID
  6. Open annotation widget within the record
  7. Annotate and Complete!

Annotation detail required

Population/Condition

InterventionComparatorOutcomes
  • Sex
  • Age 
  • Condition
  • Drug/Material/Procedure
  • Category
  • Drug/Material/Procedure
  • Category
  • Primary & Secondary
  • Category
  • dosage, schedule etc not required unless is the comparison

Terms not already in vocabulary

  • our Vocabulary browser is available HERE
Info
titleNot possible to complete the full annotation?

In some cases you will not be able to complete a full annotation. We ask that you:

  1. mark the annotation as Complete
  2. in the Annotation Action field in the CRS record select Vocabulary Request
  3. in the Annotation Notes field take note of the term requested
  4. request the missing term(s) in the Slack channel alerting Anna Last
  5. as soon as requested term(s) are available modify the annotation
  6. remove Vocabulary Request action


HTML
<a href="#com-atlassian-confluence">Back to Top</a>

Priority studies to annotate

Info
titleImportant!

These may change over time depending on topics to be coved in rapid reviews.

For both priority 1 and 2 please search for

  • studies with results (journal article or preprint article) then 
  • trial registry records

The reference type can be selected on our Study Register

Image Added

Priority 1

Intervention Assignment: Randomised 

Any of the following interventions:

  1. Hand cleaning with ash
  2. Convalescent plasma, convalescent serum or convalescent hyperimmune immunoglobulin 
  3. Any intervention in which a core component involves the use of the internet to facilitate video calls or video conferencing through computers, smartphones or tablets
  4. chloroquine, remdesivir, or corticosteroids

Priority 2

Intervention Assignment: Non-randomised or Unclear or Quasi-randomised 

Any of the following interventions:

  1. Hand cleaning with ash
  2. Convalescent plasma, convalescent serum or convalescent hyperimmune immunoglobulin 
  3. Any intervention in which a core component involves the use of the internet to facilitate video calls or video conferencing through computers, smartphones or tablets
  4. chloroquine, remdesivir, or corticosteroids

Searching to identify priority trials

  1. Restrict to Study Type: Interventional
  2. For the specific interventions:
    1. Text search for ash* 
    2. Text search for convalescent
    3. etc.

Topics/vocabulary

  • Before you start annotating please check that the Cochrane Linked Data Vocabulary to determine whether or not terms are available
  • If not available, place your request in the covid19-study-annotation channel in Slack and alert Anna last

Vocabulary notes

Age

A number of studies will state in their inclusion criteria Aged 18 years or older. Please annotate as:

Young Adult 19-24 years or Adult 19-44 years or Middle Aged 45-64 years or Aged 65-79 years or Aged 80 and over 80+ years

Drug combinations

Use the individual drugs with AND

At Risk Of

In some studies the inclusion criteria population is 'At risk of ...' - in this case we do not annotate the condition in the Population but only as an Outcome


Table of misc. terms and their categories

Table Filter
id1589544995311_-1310814080


PICOTopicDomain TermCategory




I/C

Usual Care

Usual CareOther
I/C

Western Medicine

Usual CarePharmacological
I/C

Symptomatic treatment

Usual CareOther
I/CPlasma (and variants)
Cellular & Gene
I/CNon-convalescent PlasmaBlood PlasmaCellular & Gene
I/CSupport or Supportive CareSupportOther
I/CLiberal oxygen therapyHigh DosePharmacological
I/CConservative oxygen therapyLow DosePharmacological
O

Response rate

Therapeutic ResponsePhysiological or clinical
O

Clinical response

Therapeutic ResponsePhysiological or clinical
O

Response to treatment

Therapeutic ResponsePhysiological or clinical
O

Clinical response to treatment

Therapeutic ResponsePhysiological or clinical
O

Response to therapy

Therapeutic ResponsePhysiological or clinical
O

Finding related to therapeutic response

Therapeutic ResponsePhysiological or clinical
O

Complete response

Therapeutic ResponsePhysiological or clinical
O

Blood Routine

Blood TestPhysiological or clinical
OOxygen, ventilation etc (as requirements)
Physiological or clinical

O

Viral Load or Viral Cure

Viral LoadPhysiological or clinical
OOxygen supply, Oxygen Supplementation, Oxygen Independency etc.

Oxygen Supplementation

Physiological or clinical
OHospital or ICU stay/duration of stay/ Admission to ...
Resource use
O2019-nCOVRNA in gargle 2019-nCoV RT-PCRPhysiological or clinical
OVirus negative conversion2019-nCoV RT-PCRPhysiological or clinical
OTime for improvement of respiratory symptoms and signs (and similar)

Clinical Improvement or 

Time to clinical improvement

Physiological or clinical
OTime for temperature improvement (and similar)

Clinical Improvement or 

Time to clinical improvement

Physiological or clinical
OSex-related differences in complicationsSex-related difference AND ComplicationPhysiological or clinical
OBreathing frequencyRate of RespirationPhysiological or clinical
OImmunoglobulin G COVID-19 antibodiesImmunoglobulin G COVID-19 antibodiesPhysiological or clinical
OImmunoglobulin M COVID-19 antibodiesImmunoglobulin M COVID-19 antibodiesPhysiological or clinical
OComplete remission of clinical signs of diseaseClinical resolutionPhysiological or clinical
I/CQuarantine
Behavioural


Time to ...

Time to Clinical Improvementhttps://data.cochrane.org/concepts/1ZAQeEkwo0cpmW
Time to Clinical Recoveryhttps://data.cochrane.org/concepts/OW7PMP5pAaCBgR
Time to defervescencehttps://data.cochrane.org/concepts/6nyXkn9P8DIPG3
Time to cough Cough
Time to Dyspnea Dyspnea

Time till the virus nucleic acid test goes negative/

Transition time of novel coronavirus nucleic acid"

2019-nCoV RT-PCR


Outcome annotation examples

StudyOutcomeOutcome detailAnnotation
NCT04278963respiratory progressionDefined as: SPO2≤ 93% on room air or PaO2/FiO2≤ 300mmHg and requirement for supplemental oxygen or more advanced ventilator support Hypoxia AND (Oxygen therapy OR mechanical ventilation) - all in the same outcome group